Texas A&M Rangel College of Pharmacy researcher receives a grant from the FDA to develop a test method for finding therapeutic equivalency of topical eye medications. The test method will show whether the medication is equally effective in both the brand and generic formulations. It will also reduce the amount of time and money required for a generic medication to reach the pharmacy shelf.
All hydrocodone combination products will be reclassified and more strictly regulated beginning October 2014, experts from the Texas A&M Rangel College of Pharmacy share what this means for consumers.
Andrew Himsel, a fourth-year professional student pharmacist at the Texas A&M Rangel College of Pharmacy, recently completed a rotation with the Food and Drug Administration where he practiced in programs, such as the Drug Shortage Program, Office of Compliance and the Division of Pharmacovigiliance.